نتایج جستجو برای: hbsag mutation

تعداد نتایج: 296137  

Journal: :iranian journal of virology 0
a ghaziasadi hepatitis b molecular laboratory, department of virology, school of public health, tehran university of medical sciences, tehran, iran m ziai department of internal medicine, birjand university of medical sciences, birjand, iran m norouzi department of internal medicine, birjand university of medical sciences, birjand, iran r malekzadeh digestive disease research center, shariati hospital, tehran, iran sm alavian baqiyatallah university of medical sciences, baqiyatallah research centre for gastroenterology and liver disease, tehran, iran m judaki hepatitis b molecular laboratory, department of virology, school of public health, tehran university of medical sciences, tehran, iran

background and aims: the aim of this study was to determine the correlation between the hepatitis b virus surface ag (hbsag) genotypes and variations in the clinical/serological pictures among hbsag positive chronic patients from south khorasan province of iran. methods: twenty-five patients were enrolled in this study. the hbs ag gene was amplified and was directly sequenced. genotypes and nuc...

2015
Maria Belopolskaya Viktor Avrutin Sergey Firsov Alexey Yakovlev

BACKGROUND Viral load measurement is necessary to estimate mother-to-child transmission risk for women with chronic hepatitis B (CHB), however, it is expensive. The present study aimed to investigate the relationship between HBsAg and hepatitis B virus (HBV) DNA levels, and to determine potential applications of HBsAg level monitoring for estimating viral load. METHODS 85 patients with CHB (3...

2015
Nasrin Rastegarvand Manoochehr Makvandi Alireza Samarbafzadeh Mojtaba Rasti Niloofar Neisi Amir Pouremamali Ali Teimoori Abdolnabi Shabani

BACKGROUND Occult hepatitis B infection (OBI) is a major public health problem worldwide, which harbors potential risk of hepatitis B virus (HBV) transmission through blood transfusion and transplantation. OBI is characterized by the presence of HBV-DNA in the blood or liver tissue without detectable hepatitis B surface antigen (HBsAg) in the serum. An important cause of OBI is the occurrence o...

Journal: :Antiviral therapy 2008
Johannes Wiegand Heiner Wedemeyer Andrea Finger Benjamin Heidrich Jens Rosenau Gerd Michel C Thomas Bock Michael P Manns Hans L Tillmann

BACKGROUND The elimination of hepatitis B virus surface antigen (HBsAg) is the final goal of hepatitis B treatment, but is rarely achieved. As quantitative assays for HBsAg recently became available, we have investigated whether quantitative HBsAg measurements can substitute for hepatitis B virus (HBV) DNA quantification in treatment monitoring. METHODS Within this study, 23 liver transplant ...

2012
Edouard Tuaillon Anne-Marie Mondain Nicolas Nagot Laure Ottomani Dramane Kania Erika Nogue Pierre-Alain Rubbo Georges-Philippe Pageaux Philippe Van de Perre Jacques Ducos

BACKGROUND The decline in hepatitis B virus surface antigen (HBsAg) may be an early predictor of the viral efficacy of Hepatitis B virus (HBV) therapy. The HBsAg levels obtained by different immunoassays now need comparing and the relationships between levels of HBsAg and HBV DNA alongside HBsAg and genotype must be evaluated. METHODOLOGY/PRINCIPAL FINDINGS HBsAg levels were compared among 80...

Journal: :The Journal of infectious diseases 2009
Ming-Lung Yu Chuan-Mo Lee Wan-Long Chuang Sheng-Nan Lu Chia-Yen Dai Jee-Fu Huang Zu-Yau Lin Tsung-Hui Hu Chien-Hung Chen Chao-Hung Hung Jin-Houng Wang Chi-Ling Chen Jia-Horng Kao Ming-Yang Lai Chen-Hua Liu Tung-Hung Su Shun-Sheng Wu Li-Ying Liao Hsing-Tao Kuo You-Chen Chao Shui-Yi Tung Sien-Sing Yang Pei-Jer Chen Chun-Jen Liu Ding-Shinn Chen

BACKGROUND With use of peginterferon alfa-2a and ribavirin combination therapy in patients with dual chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, 11.2% of patients achieved clearance of hepatitis B surface antigen (HBsAg) at 6 months after treatment; however, reactivation of HBV DNA was observed in 36.3%. We investigated the predictive potential of HBsAg quantification...

Journal: :Journal of virology 1995
R Schirmbeck W Böhm K Ando F V Chisari J Reimann

The efficiency of different vaccination techniques to prime in vivo major histocompatibility complex class I-restricted murine cytotoxic T-lymphocyte (CTL) precursors to hepatitis B virus small surface antigen (HBsAg) was investigated. Mice were immunized either by injection of a low dose of recombinant HBsAg protein preparations (native HBsAg particles or denatured HBsAg monomers) without adju...

Journal: :Frontiers in Public Health 2021

Background: Hepatitis B surface antigen (HBsAg) and viral load are important clinical indicators for antiviral therapy. Few studies have evaluated sequence biomarkers predicting the risk of hepatocellular carcinoma (HCC) in stage, which show a low serological response (HBsAg < 100 IU/ml) high levels (HBV DNA > 2,000 IU/ml). This study aims to determine trend biological prevalence ...

2018
Peng Hu Jia Shang Wenhong Zhang Guozhong Gong Yongguo Li Xinyue Chen Jianning Jiang Qing Xie Xiaoguang Dou Yongtao Sun Yufang Li Yingxia Liu Guozhen Liu Dewen Mao Xiaoling Chi Hong Tang Xiaoou Li Yao Xie Xiaoping Chen Jiaji Jiang Ping Zhao Jinlin Hou Zhiliang Gao Huimin Fan Jiguang Ding Dazhi Zhang Hong Ren

Background and Aims: Hepatitis B surface antigen (HBsAg) loss is seldom achieved with nucleos(t)ide analog (NA) therapy in chronic hepatitis B patients but may be enhanced by switching to finite pegylated-interferon (Peg-IFN) alfa-2a. We assessed HBsAg loss with 48- and 96-week Peg-IFN alfa-2a in chronic hepatitis B patients with partial response to a previous NA. Methods: Hepatitis B e antigen...

2006
V V Ionasescu

Sir, I read with interest the paper by Mollica et al.1 and should like to add the results of our prospective study for comparison with other Mediterranean countries on 37 HBsAg mothers who were found among 1002 pregnant women attending a maternity hospital. Although 3.7% of the mothers were positive for HBsAg, only in 0. 1 % of cord blood specimens was HBsAg demonstrable by counter electrophore...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید